checkAd
    Startseite > Aktien > Q32 Bio > Nachrichten
    Q32 Bio Aktie
    28,24
     
    USD
    +6,21 %
    +1,65 USD
    Letzter Kurs 25.04.24 Nasdaq
    27,76
     
    USD
    100 STK
    Geldkurs 25.04.24
    28,24
     
    USD
    4.500 STK
    Briefkurs 25.04.24
    ISIN: US7469641051 · WKN: A4ZZ0Z · SYM: QTTB · USA

    Neueste Nachrichten

    Homology Medicines Declares Distribution to Common Stockholders
    18.03.24 · globenewswire · Q32 Bio
    HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
    27.02.24 · Business Wire (engl.) · Q32 Bio
    Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
    03.01.24 · globenewswire · Q32 Bio
    HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
    18.11.23 · Business Wire (engl.) · Q32 Bio
    FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders
    16.11.23 · Business Wire (engl.) · Q32 Bio
    Q32 Bio and Homology Medicines Announce Merger Agreement
    16.11.23 · globenewswire · Q32 Bio
    Homology Medicines Reports Third Quarter 2023 Financial Results
    14.11.23 · globenewswire · Q32 Bio
    Homology Medicines Reports Second Quarter 2023 Financial Results and Recent Highlights
    14.08.23 · globenewswire · Q32 Bio
    Homology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual Meeting
    16.05.23 · globenewswire · Q32 Bio
    Homology Medicines Reports First Quarter 2023 Financial Results and Recent Highlights
    11.05.23 · globenewswire · Q32 Bio
    Homology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual Meeting
    03.05.23 · globenewswire · Q32 Bio